243 related articles for article (PubMed ID: 18162604)
1. A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.
Perry M; Sanguinetti MC
Mol Pharmacol; 2008 Apr; 73(4):1044-51. PubMed ID: 18162604
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
Perry M; Sachse FB; Sanguinetti MC
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551
[TBL] [Abstract][Full Text] [Related]
3. C-Linker Accounts for Differential Sensitivity of ERG1 and ERG2 K+ Channels to RPR260243-Induced Slow Deactivation.
Gardner A; Sanguinetti MC
Mol Pharmacol; 2015 Jul; 88(1):19-28. PubMed ID: 25888115
[TBL] [Abstract][Full Text] [Related]
4. Concatenated hERG1 tetramers reveal stoichiometry of altered channel gating by RPR-260243.
Wu W; Gardner A; Sanguinetti MC
Mol Pharmacol; 2015; 87(3):401-9. PubMed ID: 25519838
[TBL] [Abstract][Full Text] [Related]
5. PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance.
Perry M; Sachse FB; Abbruzzese J; Sanguinetti MC
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20075-80. PubMed ID: 19892732
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.
Grunnet M; Abbruzzese J; Sachse FB; Sanguinetti MC
Mol Pharmacol; 2011 Jan; 79(1):1-9. PubMed ID: 20876384
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for ether-a-go-go-related gene K+ channel subtype-dependent activation by niflumic acid.
Fernandez D; Sargent J; Sachse FB; Sanguinetti MC
Mol Pharmacol; 2008 Apr; 73(4):1159-67. PubMed ID: 18218980
[TBL] [Abstract][Full Text] [Related]
9. Binding of RPR260243 at the intracellular side of the hERG1 channel pore domain slows closure of the helix bundle crossing gate.
Zangerl-Plessl EM; Wu W; Sanguinetti MC; Stary-Weinzinger A
Front Mol Biosci; 2023; 10():1137368. PubMed ID: 36911523
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of slow activation of the human ether-a-go-go related gene potassium channel.
Subbiah RN; Clarke CE; Smith DJ; Zhao J; Campbell TJ; Vandenberg JI
J Physiol; 2004 Jul; 558(Pt 2):417-31. PubMed ID: 15181157
[TBL] [Abstract][Full Text] [Related]
11. Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3.
Gardner A; Wu W; Thomson S; Zangerl-Plessl EM; Stary-Weinzinger A; Sanguinetti MC
Mol Pharmacol; 2017 Oct; 92(4):437-450. PubMed ID: 28705808
[TBL] [Abstract][Full Text] [Related]
12. Cooperative interactions between R531 and acidic residues in the voltage sensing module of hERG1 channels.
Piper DR; Rupp J; Sachse FB; Sanguinetti MC; Tristani-Firouzi M
Cell Physiol Biochem; 2008; 21(1-3):37-46. PubMed ID: 18209470
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3, a Gating Modifier of EAG Family K+ Channels.
Wu W; Gardner A; Sachse FB; Sanguinetti MC
Mol Pharmacol; 2016 Oct; 90(4):469-82. PubMed ID: 27502018
[TBL] [Abstract][Full Text] [Related]
14. A highly conserved alanine in the S6 domain of the hERG1 K+ channel is required for normal gating.
Brown S; Sonntag DP; Sanguinetti MC
Cell Physiol Biochem; 2008; 22(5-6):601-10. PubMed ID: 19088442
[TBL] [Abstract][Full Text] [Related]
15. The Link between Inactivation and High-Affinity Block of hERG1 Channels.
Wu W; Gardner A; Sanguinetti MC
Mol Pharmacol; 2015 Jun; 87(6):1042-50. PubMed ID: 25855787
[TBL] [Abstract][Full Text] [Related]
16. Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity.
Zhou J; Augelli-Szafran CE; Bradley JA; Chen X; Koci BJ; Volberg WA; Sun Z; Cordes JS
Mol Pharmacol; 2005 Sep; 68(3):876-84. PubMed ID: 15976038
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide.
Garg V; Stary-Weinzinger A; Sachse F; Sanguinetti MC
Mol Pharmacol; 2011 Oct; 80(4):630-7. PubMed ID: 21743002
[TBL] [Abstract][Full Text] [Related]
18. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
[TBL] [Abstract][Full Text] [Related]
19. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
[TBL] [Abstract][Full Text] [Related]
20. Frequency-dependent modulation of KCNQ1 and HERG1 potassium channels.
Diness TG; Hansen RS; Olesen SP; Grunnet M
Biochem Biophys Res Commun; 2006 May; 343(4):1224-33. PubMed ID: 16581021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
